NILIMA SHUKLA: Open Payments
NPI 1922189877 · GASTONIA, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,415 in 95 payments from 19 companies in 2025. Trend: 2023 $3,416 · 2024 $2,861 · 2025 $2,415
Food & beverage: $2,304Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 18 | $463 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $249 |
| Vanda Pharmaceuticals Inc. | 6 | $243 |
| ABBVIE INC. | 12 | $198 |
| Axsome Therapeutics, Inc. | 7 | $188 |
| Neurocrine BioSciences, Inc. | 4 | $180 |
| Alkermes, Inc. | 8 | $135 |
| E.R. Squibb & Sons, L.L.C. | 5 | $109 |
| Braeburn Inc. | 1 | $109 |
| Almatica Pharma LLC | 5 | $97 |
Products named: AUSTEDO XR, CAPLYTA, FANAPT, Auvelity, INGREZZA, REXULTI, ARISTADA, VRAYLAR.
Industry payments across NC — which companies pay providers there.
